Status:
COMPLETED
Dexmedetomidine vs. Propofol for Cataract Surgery
Lead Sponsor:
The Cooper Health System
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use...
Eligibility Criteria
Inclusion
- Normal renal function
- No chronic use of narcotics
- ASA PS1-3
- Males or females age 18 or older
Exclusion
- Liver disease (Child Pugh classification 1-3)
- History of chronic use of sedatives, narcotics, alcohol or illicit drugs or allergy to any the study medications
- History of 1st and 2nd degree heart block (not paced)
- Any patient with EF \< 30%
- Patients with active seizure history
- Pregnant patients (women of child bearing potential will have a preoperative pregnancy test as is standard of practice)
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00786370
Start Date
April 1 2008
End Date
April 1 2010
Last Update
February 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cooper University Hospital
Camden, New Jersey, United States, 08103